ABIMX | VWLTX | ABIMX / VWLTX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 7 years | 47 years | - |
Gain YTD | -0.410 | -0.462 | 89% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 3000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 610M | 17.5B | 3% |
Annual Yield % from dividends | 3.52 | 3.19 | 110% |
Returns for 1 year | 2.17 | -1.91 | -114% |
Returns for 3 years | -4.80 | -10.31 | 47% |
Returns for 5 years | 0.73 | -9.87 | -7% |
Returns for 10 years | N/A | -8.50 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
SHPAX | 19.28 | 0.13 | +0.68% |
Saratoga Health & Biotechnology A | |||
NWAYX | 15.30 | 0.08 | +0.53% |
Nationwide GQG US Quality Eq Eagle | |||
LMGNX | 65.44 | 0.13 | +0.20% |
ClearBridge International Growth I | |||
USAGX | 19.43 | N/A | N/A |
Victory Precious Metals and Minerals | |||
MCRTX | 49.45 | -0.44 | -0.88% |
Morgan Stanley Insight R6 |